Area of research
Hepatology · Surgery
Research interest
Research focused on Hepatocellular carcinoma and Colorectal cancer, with related work in Immunotherapy, Gastroenterology, Immune system. Notable publications include 'Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)', 'Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases', and 'Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial'.
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
SHR-8068 plus adebrelimab and bevacizumab for advanced hepatocellular carcinoma (aHCC): A phase 1b/2 study.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma
A Novel Model for the Screening of Varices in Patients With Compensated Cirrhosis: An International Multicenter Study
Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer
T-cell-based immunotherapy in colorectal cancer
Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres<sup>®</sup> in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres<sup>®</sup> Transarterial Chemoembolization in Liver Cancer (CTILC) Study
The Comprehensive Analysis of Efficacy and Safety of CalliSpheres<sup>®</sup> Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort Study
Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial
Retracted: Global microarray profiling identified <i>hsa_circ_0064428</i> as a potential immune-associated prognosis biomarker for hepatocellular carcinoma
Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial
LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo